These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6133639)

  • 21. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction.
    Miller CD; Roe MT; Mulgund J; Hoekstra JW; Santos R; Pollack CV; Ohman EM; Gibler WB; Peterson ED
    Am J Med; 2007 Aug; 120(8):685-92. PubMed ID: 17679127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of beta-blockers in the treatment of patients after infarction.
    Pratt CM; Young JB; Roberts R
    Cardiol Clin; 1984 Feb; 2(1):13-20. PubMed ID: 6152718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapy for acute myocardial infarction.
    Rich MW
    Clin Geriatr Med; 1996 Feb; 12(1):141-68. PubMed ID: 8653655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty?
    Kernis SJ; Harjai KJ; Stone GW; Grines LL; Boura JA; O'Neill WW; Grines CL
    J Am Coll Cardiol; 2004 May; 43(10):1773-9. PubMed ID: 15145098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-adrenoceptor blockade and myocardial infarction: when should treatment start and for how long should it continue?
    Baber NS; Lewis JA
    Circulation; 1983 Jun; 67(6 Pt 2):I71-7. PubMed ID: 6133647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of in-hospital initiation of cardiovascular protective therapies to improve treatment rates and clinical outcomes.
    Fonarow GC
    Rev Cardiovasc Med; 2003; 4 Suppl 3():S37-46. PubMed ID: 14564233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure.
    Bunch TJ; Muhlestein JB; Bair TL; Renlund DG; Lappé DL; Jensen KR; Horne BD; Carter MA; Anderson JL;
    Am J Cardiol; 2005 Apr; 95(7):827-31. PubMed ID: 15781009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of acute beta-blocker therapy on top of aspirin and angiotensin-converting enzyme inhibitor therapy in consecutive patients with ST-elevation acute myocardial infarction.
    Wienbergen H; Zeymer U; Gitt AK; Juenger C; Schiele R; Heer T; Towae F; Senges J;
    Am J Cardiol; 2007 May; 99(9):1208-11. PubMed ID: 17478143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mortality and reinfarction among patients using different beta-blockers for secondary prevention after a myocardial infarction.
    Andersen SS; Hansen ML; Gislason GH; Folke F; Schramm TK; Fosbøl E; Sørensen R; Rasmussen S; Abildstrøm SZ; Madsen M; Køber L; Torp-Pedersen C
    Cardiology; 2009; 112(2):144-50. PubMed ID: 18612201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-blockers and depression after myocardial infarction: a multicenter prospective study.
    van Melle JP; Verbeek DE; van den Berg MP; Ormel J; van der Linde MR; de Jonge P
    J Am Coll Cardiol; 2006 Dec; 48(11):2209-14. PubMed ID: 17161247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials.
    Cucherat M
    Eur Heart J; 2007 Dec; 28(24):3012-9. PubMed ID: 17981830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infarct size reduction: a review of clinical trials.
    Fitzsimons TJ
    J Cardiovasc Pharmacol; 1989; 14 Suppl 9():S34-7. PubMed ID: 2483230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical trials and ischaemic heart disease: can drugs reduce coronary mortality?
    Silke B; Nelson GI; Taylor SH
    Ir Med J; 1982 Aug; 75(8):297-303. PubMed ID: 6127330
    [No Abstract]   [Full Text] [Related]  

  • 34. [Why is it sometimes necessary to include a large number of patients in clinical trials?].
    Hill C
    Bull Cancer; 1989; 76(6):569-71. PubMed ID: 2570613
    [No Abstract]   [Full Text] [Related]  

  • 35. Beta blocker therapy modifies circadian rhythm acute myocardial infarction.
    Garmendia-Leiza JR; Andres-de-Llano JM; Ardura-Fernandez J; Lopez-Messa JB; Alberola-Lopez C; Casaseca-Higuera P
    Int J Cardiol; 2011 Mar; 147(2):316-7. PubMed ID: 21216479
    [No Abstract]   [Full Text] [Related]  

  • 36. [Beta-blockers after a myocardial infarction: when to discontinue safely?].
    Frijling RJ; Mosterd A; Alings AMW
    Ned Tijdschr Geneeskd; 2020 Dec; 165():. PubMed ID: 33560606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proceedings of the Workshop on Implications of Recent Beta-blocker Trials for Post-Myocardial Infarction Patients. May 25-26, 1982, National Institutes of Health, Bethesda, Maryland.
    Circulation; 1983 Jun; 67(6 Pt 2):I1-111. PubMed ID: 6133638
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevention of suboptimal beta-blocker treatment in patients with myocardial infarction.
    White CM
    Ann Pharmacother; 1999 Oct; 33(10):1063-72. PubMed ID: 10534220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early intravenous beta-blockade in acute myocardial infarction.
    Held P; Yusuf S
    Cardiology; 1989; 76(2):132-43. PubMed ID: 2568179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Confidence in results of beta-blocker postinfarction trials.
    Baber NS; Lewis JA
    Br Med J (Clin Res Ed); 1982 Jun; 284(6331):1749-50. PubMed ID: 6123363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.